Join our team in Prague for the 33rd annual ISOQOL conference.
Epidemiology Solutions
Let us help you ensure the safety of your patients by examining and understanding disease indicators and using real-world evidence to support your development and post-approval activities. Our experts can conduct research to help you understand disease distribution, risk factors, treatment patterns and impact, comorbidities, burden-of-illness, and other related factors.
The RTI team's performance was top notch and exceeded expectations. They were very professional and had the right expertise necessary for the successful execution of the project.
Prucalopride Research for US FDA Approval
Expert Epidemiology Services
Get support for your drug development, regulatory submissions, and post-market safety through rigorous literature reviews, real-world evidence studies, and database research. Our multidisciplinary team can design and execute observational studies, meta-analyses, and registry-based research to uncover insights on disease burden, treatment effectiveness, and patient outcomes across global populations.
Database Studies
Leverage databases for health economic and pharmacoepidemiology research, enhancing safety assessments, and treatment effectiveness studies
Literature Reviews
Synthesize existing scientific findings to help you evaluate current knowledge, identify gaps, and inform development decisions
Retrospective Chart Reviews
Retrospective chart reviews use real-world data to help you better understand drivers that could influence your product strategy.
Post-Authorization Studies
Strengthen safety, validate efficacy, and fulfill regulatory obligations with post-authorization studies that help you sustain market success
Benefit-Risk Assessment
Navigate benefit-risk assessments, balancing product benefits and risks to meet regulatory, reimbursement, and healthcare provider needs
Cross-Sectional Surveys
Capture current disease prevalence, treatment modalities, and risk factors to enrich your real-world evidence for dossiers and support regulatory applications
Longitudinal Surveys
Leverage the power of longitudinal studes to understand changes in health, treatment response, and real-world outcomes over time
Meta-Analysis
Use rigorous, state-of-the-art methodologies to quantitatively synthesize evidence from literature reviews and enable reliable insights for healthcare decision-making
External Control Arm Analysis
Use real-world evidence to efficiently and credibly evaluate novel treatments
Site-Based Studies
Combine the rigor of in-person clinical assessments with deep patient insights gathered through structured surveys
Feasibility Assessment
Estimate cost and timeline requirements, assess IRB needs, and determine eligibility criteria, patient availability, data source reliability, and more.
Protocol Development
Ensure rigorous scientific validity, seamless regulatory alignment, and operational efficiency from day one
Study Coordination
Comprehensive management of pharmacoepidemiologic investigations from planning through delivery
Causal Inference
Apply the target trial emulation framework to tackle challenges of analyzing RWD
Oct 19 - 20, '26
Contact our team to schedule a time to meet during DIA RWE. You can find us in the exhibit hall at table 20.
Oct 26 - 28, '26
Join us for our presentation at this year's WODC EU and meet our team at booth #315.
Session: Oct 27 16:10
Oct 27 - 29, '26
We're looking forward to returning to IMPACCT RWE this year. Reach out to our team to learn more about our services during the event.
Nov 8 - 11, '26
Bruno-Kreisky-Platz 1
1220 Vienna
Austria
We are pleased to be a year-round sponsor of ISPOR. Our team will attend, speak, and present in Vienna—see details here.